web analytics

Evaluation

Are you evaluating a patient with a cholestatic syndrome?

Has the patient received hepatic arterial infusion chemotherapy (HAIC)?

Is the patient being treated with bevacizumab or other anti-VEGF targeted therapy?

Did the cholestatic syndrome appear after the chemotherapy was started?

(3) presence of multifocal strictures and dilatations of the intrahepatic bile ducts seen on imaging studies?

Does the patient have a history of biliary tract disorder prior to chemotherapy?

Is there another diagnosis that can explain cholestasis better?

Has the patient improved after discontinuing the implicated chemotherapeutic agent?

Results

Please fill out required fields.